Analyst Ratings for LifeMD
Portfolio Pulse from Benzinga Insights
LifeMD (NASDAQ:LFMD) has received positive analyst ratings in the last quarter, with 1 bullish and 3 somewhat bullish ratings. No indifferent, somewhat bearish, or bearish ratings were reported. The average 12-month price target for LFMD is $8.5, with a high of $10.00 and a low of $7.00. This target has increased by 6.25% over the past month. Analysts rate stocks based on future earnings potential and company risk profile, typically updating their ratings quarterly or after significant company events.
November 14, 2023 | 7:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
LifeMD has received predominantly positive ratings from analysts, with an average price target of $8.5, which has seen a recent increase. This positive sentiment could influence short-term stock performance.
The positive analyst ratings and the upward revision of the price target suggest optimism about LifeMD's future performance. This can lead to increased investor confidence and potentially drive up the stock price in the short term.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100